Teva Pharmaceutical Industries Limited announced earnings guidance for full year 2024. For the full year, the company expects revenue to be $15.7 million to $16.3 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.29 USD | -0.06% | +0.25% | +56.03% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.03% | 18.45B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Limited Announces Earnings Guidance for Full Year 2024